Philip Chan, Ph.D., M.S.

Philip Chan, Ph.D., M.S., partners with life sciences organizations to design and lead real-world evidence (RWE) studies using U.S. administrative claims data. His work focuses on generating payer-relevant evidence to support product value, market access, and lifecycle strategy across oncology, rare disease, and chronic conditions.

Prior to joining Inovalon, Phil served as a Senior Observational Researcher at Ontada, where he used curated oncology electronic health record-derived data to evaluate treatment patterns, clinical outcomes, and healthcare utilization. Earlier in his career, he held healthcare analytics roles at IBM, supporting large-scale EHR data integration and applied research initiatives.

With more than 15 years of experience spanning clinical trials, epidemiology, and advanced analytics, he has authored more than 36 peer-reviewed publications, including articles in the American Journal of Managed Care and leading psychiatry journals. He has also taught graduate-level epidemiology and biostatistics and previously served as a biostatistician supporting psychiatric clinical research.

Phil holds a Ph.D. in Epidemiology and a Master of Science in Biostatistics from Case Western Reserve University, as well as a Bachelor of Arts in Biochemistry and Molecular Biology from Boston University.